Healthcare - Biotechnology - NASDAQ - CN
$ 1.04
-2.8 %
$ 80.1 M
Market Cap
-0.46
P/E
BALANCE SHEET
2.61 B
ASSETS
895 M
LIABILITIES
242 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
I-Mab
| Current Assets | 2.34 B |
| Cash & Short-Term Investments | 2.29 B |
| Receivables | 0 |
| Other Current Assets | 47.1 M |
| Non-Current Assets | 39 M |
| Long-Term Investments | 12.1 M |
| PP&E | 82.9 M |
| Other Non-Current Assets | -56 M |
| Current Liabilities | 412 M |
| Accounts Payable | 0 |
| Short-Term Debt | 7.32 M |
| Other Current Liabilities | 404 M |
| Non-Current Liabilities | 483 M |
| Long-Term Debt | 3.26 M |
| Other Non-Current Liabilities | 480 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 302.1 | 3 214.0 | 3 523.6 | 4 758.8 | 1 137.5 | 1 588.3 | 307.9 |
| Short Term Investments | 143.2 | 235.4 | 753.2 | 31.5 | 32.0 | 256.0 | 266.2 |
| Receivables | 0 | 4.8 | 286.9 | 130.5 | 8.0 | 11.0 | 0.6 |
| Inventory | 0 | (80.3) | 27.2 | (422.9) | (55.9) | (215.6) | 0 |
| Other Current Assets | 47.1 | 172.5 | 190.8 | 195.5 | 191.8 | 222.0 | 117.4 |
| Total Current Assets | 2 336.7 | 3 626.5 | 4 781.7 | 5 343.7 | 1 361.3 | 2 036.9 | 691.6 |
| PP&E | 82.9 | 124.0 | 158.5 | 40.3 | 46.5 | 27.7 | 22.3 |
| Intangible Assets | 16.7 | 118.9 | 119.7 | 120.4 | 148.8 | 148.8 | 148.8 |
| Goodwill | 101.4 | 162.6 | 162.6 | 162.6 | 162.6 | 162.6 | 162.6 |
| Long Term Investments | 12.1 | 30.9 | 380.3 | 664.8 | 0 | 0 | 0 |
| Other Long Term Assets | (174.1) | 10.9 | 26.6 | 2.0 | 18.3 | 0 | 0 |
| Other Assets | 237.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 2 613.0 | 4 073.7 | 5 629.4 | 6 333.8 | 1 737.6 | 2 375.9 | 1 025.3 |
| LIABILITIES | |||||||
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short Term Debt | 7.3 | 22.4 | 30.7 | (33.6) | 56.8 | 80.0 | 82.4 |
| Other Current Liabilities | 371.9 | 637.3 | 593.3 | 567.4 | 531.7 | 266.2 | 80.3 |
| Total Current Liabilities | 411.8 | 659.7 | 624.0 | 576.1 | 588.5 | 346.2 | 195.1 |
| Long Term Debt | 3.3 | 32.1 | 163.6 | 5.5 | 75.7 | 67.0 | 114.0 |
| Deferred Tax Income | 0 | 0 | 96.9 | (9.0) | 0 | 0 | 0 |
| Other Liabilities | 479.7 | 373.5 | 30.1 | 125.0 | 3 108.1 | 2 917.9 | 1 016.0 |
| Total Liabilities | 894.8 | 1 065.3 | 1 041.6 | 706.6 | 3 772.3 | 3 331.0 | 1 325.1 |
| EQUITY | |||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 6 K | 6 K | 6 K |
| Retained Earnings | (8 327.8) | (6 766.7) | (4 354.8) | (2 023.3) | (2 494.2) | (1 014.5) | (357.9) |
| Other Accumulative Comprehensive Income/Loss | 298.3 | 216.7 | (186.5) | (50.8) | 70.1 | 59.4 | 5.7 |
| Total Equity | 242.4 | 3 008.3 | 4 587.8 | 5 627.1 | (2 034.7) | (955.1) | 5.9 |
| Total Liabilities and Equity | 2 613.0 | 4 073.7 | 5 629.4 | 6 333.8 | 1 737.6 | 2 375.9 | 1 025.3 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 83.2 | 82.5 | 75.9 | 68.2 | 3.2 | 2.8 | 2.5 |